← Leaderboards
Inderbir Gill
University Of Southern California
$1,251,091
Attributed
$2,502,181
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $810.8K · FY2016–19$1M$750K$500K$250K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$2,502,181 · 2
By mechanism
R01$2,107,418 · 1
R21$394,763 · 1
Top collaborators
- Mariana C Stern4 shared
- Gangning Liang2 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Lin Zhang$14,677,842
- Mariana C Stern$2,406,912
- Nicholas Mancuso$5,509,968
- Jesse T-P Yen$2,252,230
- Hossein Jadvar$3,348,579
Others in their field
Top investigators on “Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$257,543,614
- Charles A Coltman · Southwest Oncology Group$181,133,593
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Larry Arthur$62,719,328
- William J. Blot · Vanderbilt University$62,640,427
- Walter John Curran · Thomas Jefferson University$60,981,384
Research focus
ProstateSuccessIndolentNeedlesRadiation TherapySpecimenEnrollmentImageMagnetic Resonance ImagingMalignant NeoplasmsProstate BiopsyQuality Of LifeRadical ProstatectomySensitivity And SpecificityDiagnosisBiopsyBiopsy SpecimenClinically SignificantClinical ManagementLesionBaseMalignant Neoplasm Of ProstateDiagnosticTumor
Grant awards (6)
Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy$657,431
R01 · FY2019 · CA · contact PI
Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy$340,175
R01 · FY2018 · CA · contact PI
Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy$514,292
R01 · FY2017 · CA · contact PI
Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness$179,438
R21 · FY2017 · CA
Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy$595,520
R01 · FY2016 · CA · contact PI
Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness$215,325
R21 · FY2016 · CA